Relief Therapeutics Holding AG (RLFTF)

[changes_iv]

OUTRAGE!!

WASHINGTON — The Food and Drug Administration fast-tracked Biogen’s divisive Alzheimer’s drug Aduhelm, but it’s not going to do the same for amyotrophic lateral sclerosis anytime soon — and ALS advocates are outraged.

https://www.statnews.com/2021/06/11/advocates-blast-fda-for-not-fast-als-alzheimers/

Vasoactive Intestinal Peptide Decreases ß-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer's Disease. J Mol Neurosci.

https://pubmed.ncbi.nlm.nih.gov/30498985/